Rapid identification of cytokine release syndrome after haploidentical PBSC transplantation and successful therapy with tocilizumab

Bone Marrow Transplant. 2016 Dec;51(12):1620-1621. doi: 10.1038/bmt.2016.229. Epub 2016 Sep 26.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Cell Proliferation
  • Cytokines / metabolism*
  • Graft vs Host Reaction
  • Hematopoietic Stem Cell Transplantation*
  • Hodgkin Disease / therapy
  • Humans
  • Inflammation
  • Male
  • Peripheral Blood Stem Cell Transplantation*
  • Receptors, Interleukin-6 / antagonists & inhibitors
  • Systemic Inflammatory Response Syndrome / chemically induced
  • Systemic Inflammatory Response Syndrome / diagnosis*
  • Time Factors
  • Transplantation Conditioning
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Cytokines
  • Receptors, Interleukin-6
  • tocilizumab